ATE240318T1 - Substituierte bisindolylmaleimide zur inhibierung der zellproliferation - Google Patents

Substituierte bisindolylmaleimide zur inhibierung der zellproliferation

Info

Publication number
ATE240318T1
ATE240318T1 AT97934498T AT97934498T ATE240318T1 AT E240318 T1 ATE240318 T1 AT E240318T1 AT 97934498 T AT97934498 T AT 97934498T AT 97934498 T AT97934498 T AT 97934498T AT E240318 T1 ATE240318 T1 AT E240318T1
Authority
AT
Austria
Prior art keywords
bisindolylmaleimide
substituted
cell proliferation
inhibit cell
inhibit
Prior art date
Application number
AT97934498T
Other languages
German (de)
English (en)
Inventor
Donna Mary Huryn
Dennis Dalton Keith
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE240318T1 publication Critical patent/ATE240318T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
AT97934498T 1996-07-29 1997-07-19 Substituierte bisindolylmaleimide zur inhibierung der zellproliferation ATE240318T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2207996P 1996-07-29 1996-07-29
PCT/EP1997/003889 WO1998004552A1 (en) 1996-07-29 1997-07-19 Substituted bisindolylmaleimides for the inhibition of cell proliferation

Publications (1)

Publication Number Publication Date
ATE240318T1 true ATE240318T1 (de) 2003-05-15

Family

ID=21807711

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97934498T ATE240318T1 (de) 1996-07-29 1997-07-19 Substituierte bisindolylmaleimide zur inhibierung der zellproliferation

Country Status (23)

Country Link
US (2) US5856517A (cg-RX-API-DMAC7.html)
EP (1) EP0915872B1 (cg-RX-API-DMAC7.html)
JP (1) JP2000516589A (cg-RX-API-DMAC7.html)
KR (1) KR20000029637A (cg-RX-API-DMAC7.html)
CN (2) CN1151149C (cg-RX-API-DMAC7.html)
AR (1) AR008267A1 (cg-RX-API-DMAC7.html)
AT (1) ATE240318T1 (cg-RX-API-DMAC7.html)
AU (1) AU739742B2 (cg-RX-API-DMAC7.html)
BR (1) BR9711605A (cg-RX-API-DMAC7.html)
CA (1) CA2262092A1 (cg-RX-API-DMAC7.html)
CO (1) CO4900055A1 (cg-RX-API-DMAC7.html)
CY (1) CY2483B1 (cg-RX-API-DMAC7.html)
DE (1) DE69722003T2 (cg-RX-API-DMAC7.html)
DK (1) DK0915872T3 (cg-RX-API-DMAC7.html)
ES (1) ES2198001T3 (cg-RX-API-DMAC7.html)
HR (1) HRP970414A2 (cg-RX-API-DMAC7.html)
MA (1) MA24287A1 (cg-RX-API-DMAC7.html)
PE (1) PE91698A1 (cg-RX-API-DMAC7.html)
PT (1) PT915872E (cg-RX-API-DMAC7.html)
SA (1) SA97180473A (cg-RX-API-DMAC7.html)
TR (1) TR199900157T2 (cg-RX-API-DMAC7.html)
WO (1) WO1998004552A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA976492B (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200002580T2 (tr) * 1998-03-17 2000-11-21 F.Hoffmann-La Roche Ag Hücre çoğalmasının engellenmesinde kullanılan ikameli bisindolimaleimitler
WO2001044247A2 (en) * 1999-12-16 2001-06-21 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
ATE267194T1 (de) * 1999-12-16 2004-06-15 Lilly Co Eli Medikamente geeignet zur behandlung von proliferativen erkrankungen
US6743785B2 (en) * 1999-12-16 2004-06-01 Eli Lilly And Company Agents and methods for the treatment of proliferative diseases
US6313143B1 (en) * 1999-12-16 2001-11-06 Hoffmann-La Roche Inc. Substituted pyrroles
US6281356B1 (en) * 1999-12-22 2001-08-28 Hoffmann-La Roche Inc. Substituted pyrroles
TWI335221B (en) 2001-09-27 2011-01-01 Alcon Inc Inhibtors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
MY142390A (en) * 2002-05-22 2010-11-30 Glaxosmithkline Llc 3' - [(2z)-[1-(3,4-dimethylphenyl)-1,5- dihydro-3- methyl-5-0xo-4h-pyrazol-4- ylidene]hydrazino]-2' -hydroxy -[1,1' -biphenyl]-3-carboxylic acid bis-(monoethanolamine)
US7012100B1 (en) 2002-06-04 2006-03-14 Avolix Pharmaceuticals, Inc. Cell migration inhibiting compositions and methods and compositions for treating cancer
SI1846406T1 (sl) 2005-02-09 2011-02-28 Arqule Inc Maleimidni derivati, farmacevtski sestavki in postopki za zdravljenje raka
MX2009006533A (es) * 2006-12-19 2009-06-26 Novartis Ag Derivados de indolil-maleimida como inhibidores de cinasa.
US8232285B2 (en) 2007-06-22 2012-07-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
CA2690799C (en) 2007-06-22 2015-06-16 Arqule, Inc. Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer
US8513292B2 (en) 2007-06-22 2013-08-20 Arqule, Inc. Compositions and methods for the treatment of cancer
JP2009035537A (ja) * 2007-07-10 2009-02-19 Nippon Synthetic Chem Ind Co Ltd:The Ｎ−置換アニリン誘導体及び１−置換インドール誘導体の製造方法
FR2927075A1 (fr) * 2008-02-04 2009-08-07 Centre Nat Rech Scient Molecules comprenant un squelette bis-(heteroaryl)maleimide, et leur utilisation dans l'inhibition d'enzymes
GB201111427D0 (en) * 2011-07-05 2011-08-17 Amakem Nv Novel bisindolylmaleimides, pan-pkc inhibitors
AU2015217152A1 (en) 2014-02-11 2016-08-11 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease
JP2017524739A (ja) 2014-07-17 2017-08-31 アンセルムＩｎｓｅｒｍ 神経筋接合部関連疾患の処置方法
WO2016207366A1 (en) 2015-06-26 2016-12-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of viral infections
AU2018290225A1 (en) * 2017-06-21 2020-01-23 Mitokinin, Inc. Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89167A (en) * 1988-02-10 1994-02-27 Hoffmann La Roche Substituted pyrroles, their manufacture and pharmaceutical compositions containing them
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
CA2015996C (en) * 1989-05-05 2001-08-28 Hartmut Osswald Bis-(1h-indol-3-yl)-maleinimide derivatives and their use as pharmaceuticals
DE4005969A1 (de) * 1990-02-26 1991-08-29 Boehringer Mannheim Gmbh Neue trisubstituierte pyrrole, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
JPH0539289A (ja) * 1991-02-15 1993-02-19 Masahiro Irie 無水マレイン酸誘導体およびその製造方法
WO1993018765A1 (en) * 1992-03-20 1993-09-30 The Wellcome Foundation Limited Indole derivatives with antiviral activity
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung

Also Published As

Publication number Publication date
US6030994A (en) 2000-02-29
US5856517A (en) 1999-01-05
KR20000029637A (ko) 2000-05-25
HRP970414A2 (en) 1998-06-30
PE91698A1 (es) 1998-12-24
EP0915872B1 (en) 2003-05-14
BR9711605A (pt) 1999-08-24
CY2483B1 (en) 2005-06-03
DE69722003T2 (de) 2004-04-01
CO4900055A1 (es) 2000-03-27
ZA976492B (en) 1998-01-29
PT915872E (pt) 2003-09-30
SA97180473A (ar) 2005-12-03
DE69722003D1 (de) 2003-06-18
JP2000516589A (ja) 2000-12-12
WO1998004552A1 (en) 1998-02-05
CN1151149C (zh) 2004-05-26
ES2198001T3 (es) 2004-01-16
EP0915872A1 (en) 1999-05-19
AU3769097A (en) 1998-02-20
AR008267A1 (es) 1999-12-29
MA24287A1 (fr) 1998-04-01
TR199900157T2 (xx) 1999-04-21
CA2262092A1 (en) 1998-02-05
AU739742B2 (en) 2001-10-18
CN1495182A (zh) 2004-05-12
CN1226247A (zh) 1999-08-18
DK0915872T3 (da) 2003-09-08

Similar Documents

Publication Publication Date Title
ATE224889T1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
ATE240318T1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
DE69739407D1 (de) Plattenstruktur
ID19875A (id) Poliolefin yang dimodifikasi menurut reologi
NO984316D0 (no) Skjµreverkt°y
DE69727942D1 (de) Transplantat-gewebekonstruktion zum ersatz der knorpelstruktur
NO983462D0 (no) Isoleringsverkt°y
ID24314A (id) Tempat umpan bersekat-sekat
DE69718481D1 (de) Elektrolyt
ATE243693T1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
NO990552D0 (no) Innrettingsverkt°y
ATE347551T1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
EP1039897A4 (en) COMPOUNDS BASED ON INADONE AND TETRALONE FOR INHIBITING CELL PROLIFERATION
ID17786A (id) Sel fotoelektrokima
DE69716061D1 (de) Pyrrolderivate
ATE306484T1 (de) Substituierte bisindolylmaleimide zur inhibierung der zellproliferation
FI961983L (fi) Multivibraattoripiiri
FI961658A7 (fi) Laitteisto sähköenergian kulutuksen mittaamiseksi
ATA196697A (de) Panzerungsplatte
FI961981L (fi) Multivibraattoripiiri
ID16641A (id) Peralatan elektromagnit untuk mengukur tenaga listrik
FR2743284B1 (fr) Assiette papillote
FI961982A0 (fi) Multivibratorkrets
ID18647A (id) Gurdi bor bebatuan
ID18947A (id) Pesawat untuk menjepit piringan

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0915872

Country of ref document: EP

REN Ceased due to non-payment of the annual fee